Nasdaq Biotech Company Makes Bold Move, Investing $888M in HYPE Cryptocurrency by Committing Treasury Funds to the Digital Token
Hyperliquid Strategies Inc (HSI) has been formed through a business combination between Sonnet BioTherapeutics and Rorschach I LLC. The new entity, which is set to become a public cryptocurrency treasury company, will focus on holding and managing reserves of the HYPE token, associated with the Hyperliquid Layer-1 blockchain.
Under the terms of the deal, HSI will hold 12.6 million HYPE tokens worth around $583 million, and will also receive $305 million in cash. This gives HSI a total valuation of approximately $888 million.
The formation of HSI marks a strategic shift for Sonnet BioTherapeutics, which is moving away from its biotechnology roots towards crypto treasury management. The merger brings onboard prominent investors such as Paradigm, Galaxy Digital, Pantera Capital, D1 Capital, Republic Digital, and 683 Capital.
HSI's focus on the HYPE token is to establish one of the largest U.S.-listed public company reserves of this cryptocurrency, capitalising on its potential and supporting its ecosystem. Sonnet will remain a wholly owned subsidiary of HSI and will continue some of its biotech operations, but primarily HSI's business will revolve around building and managing a substantial treasury of HYPE tokens for strategic and investment purposes.
Technical Advantages of Hyperliquid
Hyperliquid is an emerging Layer-1 blockchain known for its high-throughput on-chain trading infrastructure. Its consensus mechanism, HyperBFT, facilitates its speed and scalability, forming part of the technology advantage against established chains. HyperCore powers on-chain perpetual futures and supports up to 200,000 orders per second, while HyperEVM extends HyperCore's liquidity to dApps and developers.
As of July 6, HYPE is the 13th-largest cryptocurrency by market cap, and U.S. investors won't be able to buy it easily, which HSI sees as an opportunity to offer indirect exposure through equity markets. The scarcity of HYPE offers an attractive framework for HSI as a public equity proxy for tokens.
Leadership and Board Members
David Schamis, also of Atlas, will become CEO of HSI. Bob Diamond, Co-founder and CEO of Atlas Merchant Capital, will serve as Chairman of HSI. Two independent directors from Sonnet will also join the board of HSI. Eric Rosengram, former President of the Boston Federal Reserve, will join the board of HSI.
Sonnet raised $5.5 million via a private placement of convertible preferred shares and warrants to support the transition. The new entity, HSI, will remain listed on Nasdaq under a new ticker, becoming one of the largest public holders of HYPE globally.
The revival in confidence in the cryptocurrency market, driven by a new market cycle and increasing institutional involvement, is influencing the formation of entities like HSI. Matt Huang, Co-founder of Paradigm, stated that Hyperliquid has strong fundamentals, including high product quality, a rapidly growing community, and technical capabilities that rival Ethereum.
[1] Hyperliquid Strategies Inc Press Release
[2] CoinDesk Article on Hyperliquid Strategies Inc
[3] Bloomberg Article on Hyperliquid Strategies Inc
- Hyperliquid Strategies Inc (HSI) was formed through a business combination between Sonnet BioTherapeutics and Rorschach I LLC, becoming a public cryptocurrency treasury company focused on Bitcoin, Ethereum, and other tokens.
- The new entity, HSI, will hold 12.6 million HYPE tokens worth around $583 million, along with $305 million in cash, giving it a total valuation of approximately $888 million.
- Sonnet BioTherapeutics is moving away from its biotechnology roots towards crypto treasury management, and HSI's primary business will revolve around building and managing a substantial treasury of HYPE tokens for strategic and investment purposes.
- Hyperliquid, the Layer-1 blockchain associated with HYPE tokens, is known for its high-throughput on-chain trading infrastructure, offering advantages over established chains due to its speed, scalability, and technology like HyperBFT, HyperCore, and HyperEVM.
- HSI sees the scarcity of HYPE tokens as an opportunity to offer indirect exposure through equity markets, capitalizing on its potential and supporting its ecosystem.
- The revival in confidence in the cryptocurrency market, driven by a new market cycle and increasing institutional involvement, is influencing the formation of entities like HSI.
- Prominent investors such as Paradigm, Galaxy Digital, Pantera Capital, D1 Capital, Republic Digital, and 683 Capital are onboard with HSI, and Eric Rosengram, former President of the Boston Federal Reserve, will join the board of HSI.
- HSI aims to establish one of the largest U.S.-listed public company reserves of HYPE and support decentralized finance (DeFi) through dapps (decentralized applications) built on the Hyperliquid blockchain, ultimately disrupting traditional finance with innovative business models and technology.
